The Michael J. Fox Foundation supports studies with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care.
Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program advances Parkinson's disease therapeutic and intervention development along the pre-clinical and clinical path.
The program supports work toward therapies aiming to address one of the following treatment challenges:
- Protection or restoration of degenerating and/or dysfunctional neurons affected in Parkinson’s
- Alleviation of disabling motor or non-motor symptoms of Parkinson’s not well managed by current treatments
- Reduction of complications and side effects of current Parkinson’s treatments.
Pharmacological interventions as well as biologic, gene therapy, surgical and non-invasive/non-pharmaceutical approaches are appropriate.
Webinars for Researchers
View our library of webinars around funding programs and field updates.
Contact email@example.com with questions.